Mayer EL, Tayob N, Ren S, Savoie JJ, et al. A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer. Breast Cancer Res Treat 2023 Nov 29. doi: 10.1007/s10549-023-07167.
PMID: 38019444